基于MRI的影像组学模型预测晚期高级别浆液性卵巢癌复发风险
本研究回顾性纳入117例晚期高级别浆液性卵巢癌患者,从T2加权和增强T1加权图像提取1046个影像组学特征,使用LASSO回归筛选特征、SMOTE平衡数据、SVM构建分类模型,并以留一交叉验证评估。融合影像组学模型预测无复发生存的AUC为0.85,显著高于单独增强T1(AUC=0.79)或单独T2(AUC=0.74)模型;融合影像组学与临床信息的模型C-index为0.62,高于临床模型0.60。结论提示基于MRI的影像组学特征有助于识别高复发风险的晚期HGSOC患者。
要点
- 融合T2WI与增强T1WI影像组学特征预测RFS的AUC达0.85,优于单一序列模型。
- 影像组学联合临床信息模型C-index为0.62,略高于临床模型0.60。
- 术前MRI影像组学模型或可辅助识别晚期HGSOC高复发风险患者。
核心结论
- 基于术前MRI的影像组学特征建立的融合模型对晚期HGSOC的RFS具有较好的预测效能,有助于识别高复发风险患者。
研究设计与样本
- 回顾性研究纳入117例晚期高级别浆液性卵巢癌患者,其中复发90例、未复发27例。
- 从T2加权图像和增强T1加权图像中手动分割提取1046个影像组学特征。
- 采用L1正则化LASSO回归筛选特征,SMOTE技术平衡数据集,SVM分类器构建模型。
- 以留一交叉验证方法训练和测试分类器,用Cox比例风险回归、Harrell C-index和Kaplan-Meier分析评估影像组学特征与RFS的关联。
诊断标准与关键数值
- 融合影像组学模型评估RFS的AUC为0.85,显著高于单独增强T1WI模型(AUC=0.79,P=.02)和单独T2WI模型(AUC=0.74,P=.01)。
- 融合影像组学与临床信息的模型C-index为0.62,高于临床模型C-index=0.60。
- Kaplan-Meier生存曲线显示不同模型划分的高、低复发风险组间存在显著差异。
临床应用与阅片要点
- 术前可基于T2WI和增强T1WI提取影像组学特征,辅助评估晚期HGSOC复发风险分层。
- 融合多序列影像组学特征较单一序列能提供更优的预测效能,阅片时需关注多序列信息整合。
局限性
- 本研究为回顾性单中心设计,样本量有限(117例),结论需外部验证。
- 采用手动分割提取特征,可重复性和推广性可能受限。
- 未报告外部验证队列结果,模型泛化能力尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The purpose of our study was to develop a radiomics model based on preoperative MRI and clinical information for predicting recurrence-free survival (RFS) in patients with advanced high-grade serous ovarian carcinoma (HGSOC). MATERIALS AND METHODS. This retrospective study enrolled 117 patients with HGSOC, including 90 patients with recurrence and 27 without recurrence; 1046 radiomics features were extracted from T2-weighted images and contrast-enhanced T1-weighted images using a manual segmentation method. L1 regularization-based least absolute shrinkage and selection operator (LASSO) regression was performed to select features, and the synthetic minority oversampling technique (SMOTE) was used to balance our dataset. A support vector machine (SVM) classifier was used to build the classification model. To validate the performance of the proposed models, we applied a leave-one-out cross-validation method to train and test the classifier. Cox proportional hazards regression, Harrell concordance index (C-index), and Kaplan-Meier plots analysis were used to evaluate the associations between radiomics signatures and RFS. RESULTS. The fusion radiomics-based model yielded a significantly higher AUC value of 0.85 in evaluating RFS than the model using contrast-enhanced T1-weighted imaging features alone or T2-weighted imaging features alone (AUC = 0.79 and 0.74 and p = .02 and .01, respectively). Kaplan-Meier survival curves showed significant differences between high and low recurrence risk in patients with HGSOC by different models. The fusion model combining radiomics features and clinical information showed higher performance than the clinical model (C-index = 0.62 and 0.60, respectively). CONCLUSION. The proposed MRI-based radiomics signatures may provide a potential way to develop a prediction model and can help identify patients with advanced HGSOC who have a high risk of recurrence.
引用
- Li HM, Gong J, Li RM, et al. Development of MRI-Based Radiomics Model to Predict the Risk of Recurrence in Patients With Advanced High-Grade Serous Ovarian Carcinoma. AJR Am J Roentgenol. 2021. PMID: 34259544. doi:10.2214/AJR.20.23195
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。